FREQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Nov 2023 @ 16:00):

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function...

Stats
Today's Volume	309 164
Average Volume	135 075
Market Cap	10.94M
EPS	$0 ( 2024-03-08 )
Next earnings date	( $0 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.158
ATR14	$0.0510 (17.02%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-27	Meyers Rachel	Buy	12 551	Stock Option (Right to Buy)
2023-11-27	Meyers Rachel	Buy	0
2023-11-22	Lucchino David L.	Sell	110	Common Stock
2023-11-22	Lucchino David L.	Sell	230	Common Stock
2023-11-22	Lucchino David L.	Sell	614	Common Stock

INSIDER POWER
96.45
Last 81 transactions
Buy: 3 077 272 \| Sell: 64 406

Volume Correlation

Long: 0.24 (neutral)

Short: -0.40 (neutral)

Signal:(51.699) Neutral

Frequency Therapeutics Correlation

10 Most Positive Correlations
AMGN	0.895
REVB	0.883
GLPG	0.882
STAF	0.873
GMII	0.873
ZYXI	0.872
SNES	0.871
IMPL	0.867
YQ	0.866
LBTYK	0.864

10 Most Negative Correlations
SHSP	-0.952
MMAC	-0.944
BNFT	-0.922
XOG	-0.904
EXFO	-0.895
GTYH	-0.89
MNTX	-0.887
ANDA	-0.886
COUP	-0.884
FTNT	-0.868

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Frequency Therapeutics Correlation - Currency/Commodity

0.57
( weak )

0.48
( neutral )

0.00
( neutral )

-0.10
( neutral )

0.69
( moderate )

0.01
( neutral )

Frequency Therapeutics Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-2.33

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-2.33

FY	2021
Revenue:	$14 068.00
Gross Profit:	$14 068.00 (100.00 %)
EPS:	$-0.00246

FY	2020
Revenue:	$36.98M
Gross Profit:	$36.98M (100.00 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Frequency Therapeutics

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Realtime updates for Frequency Therapeutics [FREQ]

Upcoming Earnings Alert